Trinity Biotech PLC

TRIB

Exchange: Nasdaq
Industry: In Vitro & In Vivo Diagnostic Substances
SEC CIK: 0000888721

SEC filings (opens in a new tab)

No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Trinity Biotech PLC changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of TRIB: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	20	20	0
Shares	6.20M	6.14M	−67.1K (−1.1%)
Value	$5.93M	$4.49M	−$1.43M (−24.2%)

New holders (1)

Institutions that held Trinity Biotech PLC at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to TRIB in Q3 2023
Institution	Shares	Value	% of portfolio
UBS Group AG	142	$104	0.00%

Sold out (1)

Institutions that held Trinity Biotech PLC at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of TRIB in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Citadel Advisors LLC	37,622	$36.3K